Rx of reality from Stanford:
Article · September 2016
A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer R...
Journal of Oncology Practice
Derrick S Haslem, S Burke Van Norman, Gail Fulde, ...
A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs
Article in Journal of Oncology Practice · September 2016
DOI: 10.1200/JOP.2016.01148
THE ARTICLE IS BASICALLY SAYING that cancer immunology makes sense with early diagnosis and biomarker technology. YES! The timing of the article and the PPHM announcement creates a nice synergism. Now I hope all here understand the futility of treating advanced cancers with immunological agents, but the great value of the spin-off information derived therefrom. I notice that Steve King thanked everyone but the holders of common stock who made this inquiry possible. Hey Steve?!? It's been a long, loan-some haul for some here.
Market Data 
Markets 
AI
